Sonidegib
ATC L01XJ02 · 6 markets · 9 records
AU 4 records · 3 strengths
- 200 mgcapsuleOdomzo
- 280.8 mgcapsuleODOMZO sonidegib diphosphate 200 mg hard capsule blister packODOMZO sonidegib diphosphate 200mg hard capsule bottle
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 strengths
- 200 mgcapsuleOdomzo
CA 1 records · 1 strengths
- 200 mgcapsuleOdomzo
ES 1 records · 1 strengths
- 200 mgcapsuleOdomzo
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 280.8 mgcapsuleODOMZO 200 mg, gélule
| Strength / form / release | US | CA | AU | ES | EU | FR |
|---|---|---|---|---|---|---|
| 200 mg capsule | Odomzo | Odomzo | Odomzo | Odomzo | ||
| 280.8 mg capsule | ODOMZO sonidegib diphosphate 200 mg hard capsule blister pack ODOMZO sonidegib diphosphate 200mg hard capsule bottle | ODOMZO 200 mg, gélule | ||||
unknown | Odomzo | Odomzo |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.